quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:08:48·45d
SECFiling
Design Therapeutics Inc. logo

SEC Form 10-K filed by Design Therapeutics Inc.

DSGN· Design Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • DSGN
    Design Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 16UpdateJefferies$15.00
  • Jan 7UpdateOppenheimer$18.00
  • Dec 3UpdateLeerink Partners$14.00
  • Dec 3UpdateCraig Hallum$15.00
  • Nov 20UpdateRBC Capital Mkts$13.00
  • May 7UpdatePiper Sandler$12.00

Related

  • SEC13h
    SEC Form DEFA14A filed by Design Therapeutics Inc.
  • SEC13h
    SEC Form DEF 14A filed by Design Therapeutics Inc.
  • INSIDER22d
    SEC Form 4 filed by Shapiro David
  • INSIDER22d
    SEC Form 3 filed by new insider Shapiro David
  • SEC22d
    Design Therapeutics Inc. filed SEC Form 8-K: Leadership Update
  • ANALYST38d
    Jefferies initiated coverage on Design Therapeutics with a new price target
  • SEC45d
    SEC Form S-8 filed by Design Therapeutics Inc.
  • SEC45d
    Design Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022